Salicylic acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by their rough, “cauliflower-like” surface appearance. Additionally, it is indicated for the removal of plantar warts, which are specifically located on the bottom of the foot and are identified by tenderness and disruption of the footprint pattern.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. For optimal results, it is recommended to soak the wart in warm water for approximately 15 minutes. After soaking, the area must be dried completely.

A thin layer of the product should be applied directly to each wart. Following application, the affected area should be covered with a clean bandage to protect it. This procedure may be repeated daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• Patients with diabetes, due to potential complications associated with impaired wound healing.

• Application on irritated, infected, or reddened skin, as this may exacerbate the condition.

• Individuals with poor blood circulation, which may hinder proper healing and increase the risk of adverse effects.

• Use on warts with hair growing from them is contraindicated, as this may lead to further irritation or infection.

• Application on moles or birthmarks is not recommended due to the risk of altering these skin features.

• The product should not be applied to the face, genitals, or mucous membranes, as these areas are more sensitive and susceptible to irritation.

Additionally, avoid contact with eyes and mucous membranes during use. If irritation occurs or discomfort persists, discontinue use and consult a healthcare professional.

Warnings and Precautions

For external use only. It is imperative to adhere to the following warnings and precautions to ensure safe usage of the product.

General precautions include the necessity of keeping the product out of reach of children and pets. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

This product is contraindicated for individuals with diabetes. It should not be applied to irritated, infected, or reddened skin. Additionally, individuals with poor blood circulation should refrain from using this product. It is also not recommended for application on warts with hair growth, moles, or birthmarks. The product should not be used on the face, genitals, or mucous membranes.

In case of irritation or persistent discomfort, it is essential to discontinue use and consult a healthcare professional.

Side Effects

For external use only. Patients should be advised to stop use and consult a doctor if irritation occurs or if discomfort persists. Prior to use, individuals with diabetes, poor blood circulation, or any other serious skin conditions in the area being treated should seek medical advice.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Supreh Solid Wart Remover Stick. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children and pets. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

No information related to nursing mothers or lactation is provided in the drug insert for SUPREH SOLID WART REMOVER STICK. Therefore, the effects on breastfed infants and the excretion of the drug in human milk are unknown. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise. In the event of suspected overdosage, it is recommended to initiate supportive care and symptomatic treatment as necessary.

Healthcare providers should consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the individual case. Continuous assessment of the patient's clinical status is essential to ensure appropriate interventions are implemented promptly.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and pets. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients with diabetes should be informed to consult their healthcare provider before using the product. Additionally, it is important to discuss the use of the product on irritated, infected, or reddened skin, as well as on areas with poor blood circulation. Patients should be cautioned against applying the product on warts with hair growing from them, moles, or birthmarks, and to avoid use on the face, genitals, or mucous membranes.

Healthcare providers should emphasize the importance of avoiding contact with the eyes and mucous membranes. In the event that the product comes into contact with the eyes, patients should be instructed to flush the eyes with water for at least 15 minutes.

Patients should be reminded to use the product only as directed. If irritation occurs or if discomfort persists, they should seek medical attention. It is also advisable to cap the stick tightly after use to prevent it from drying out. Lastly, patients should be informed to consult a healthcare provider if they have any other serious skin conditions in the area being treated.

Storage and Handling

The product is supplied in a configuration that requires the cap to be replaced after use. It should be stored at room temperature to maintain its integrity and effectiveness. Proper handling includes ensuring that the cap is securely fastened after each use to prevent contamination and preserve the product's quality.

Additional Clinical Information

The product is administered topically, with specific directions for use. Patients should wash the affected area and may soak the wart in warm water for 15 minutes before thoroughly drying the area. A thin layer of the product should be applied to each wart, followed by covering the affected area with a clean bandage. This procedure may be repeated daily as needed, for up to 12 weeks, until the wart is removed.

Clinicians should advise patients to keep the product out of reach of children and pets. In the event of ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Supreh Solid Wart Remover Stick, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)